IDENTIFICATION OF RISK GROUPS FOR TYPE 2 DIABETES MELLITUS BASED ON FINDRISС QUESTIONNAIRE

Cover Page


Cite item

Abstract

Background: Prevalence of type 2 diabetes mellitus (T2DM) has reached an epidemic level worldwide and continues to increase steadily.

Aim: To assess appropriateness of FINDRISC questionnaire to identify groups with high risk of T2DM in the population of theMoscowregion.

Materials and methods: Four hundred and four subjects aged above 18 years in the Lukhovitsy district of theMoscowregion were screened for disturbances of carbohydrate metabolism. All participants filled in the questionnaire of the Finnish Diabetes Association, FINDRISC (the Finnish Diabetes Risk Score). An oral glucose tolerance test was performed in all subjects.

 Results: Prevalence of carbohydrate metabolism disorders in the study sample was 36.1%. Among them, newly diagnosed T2DM was found in 6.1%, impaired glucose tolerance, in 14.4%, impaired fasting glycaemia, in 18.5%, both impaired glucose tolerance and fasting glycaemia, in 5.7%. Detection of T2DM and early disorders of carbohydrate metabolism was higher in subjects with higher FINDRISC scores. The screening model that includes diagnostic assessment of subjects with a score of≥12 of this questionnaire has adequate sensitivity and specificity to detect T2DM. This model allows for reduction of the necessary sample to 37.5%. Prevalence of cardiovascular risk factors is higher in the subjects with a high FINDRISC score, compared to those with the minimal score.

Conclusion: Active implementation of FINDRISC questionnaire among the population of theMoscowregion would allow for timely detection of those with T2DM risk for further screening for disorders of carbohydrate metabolism and introduction of activities to prevent T2DM. 

About the authors

I. V. Misnikova

Moscow Regional Research and Clinical Institute (MONIKI)

Author for correspondence.
Email: inna-misnikova@mail.ru

Misnikova Inna Vladimirovna – MD, PhD, Leading Research Fellow, Department of Therapeutic Endocrinology; Professor, Chair of Endocrinology, Postgraduate Training Faculty

* 61/2–9 Shchepkina ul., Moscow, 129110, Russian Federation. Tel.: +7 (495) 688 95 93. E-mail: inna-misnikova@mail.ru

Russian Federation

A. V. Dreval'

Moscow Regional Research and Clinical Institute (MONIKI)

Email: inna-misnikova@mail.ru
Dreval' Aleksandr Vasil'evich – MD, PhD, Professor, Head of Department of Therapeutic Endocrinology; Chief of Chair of Endocrinology, Postgraduate Training Faculty Russian Federation

T. G. Dzebisashvili

Moscow Regional Research and Clinical Institute (MONIKI)

Email: inna-misnikova@mail.ru
Dzebisashvili Tampta Georgievna – Endocrinologist Russian Federation

References

  1. International Diabetes Federation. IDF Diabetes Atlas. 6th edition. Available at: http://www. idf.org/diabetesatlas
  2. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403.
  3. Древаль АВ, Мисникова ИВ, Дзебисашвили ТГ. Риск развития сахарного диабета 2 типа и острой кардиоваскулярной патологии у лиц с ранними нарушениями углеводного обмена. Клиническая медицина. 2012;80(11):30–3. (Dreval' AV, Misnikova IV, Dzebisashvili TG. [Risk for developing of type 2 diabetes mellitus and cardivascular events in people with early carbohydrate metabolism disorders]. Klinicheskaya meditsina. 2012;80(11):30–3. Russian).
  4. Schulze MB, Hoffmann K, Boeing H, Linseisen J, Rohrmann S, Möhlig M, Pfeiffer AF, Spranger J, Thamer C, Häring HU, Fritsche A, Joost HG. An accurate risk score based on anthropometric, dietary, and lifestyle factors to predict the development of type 2 diabetes. Diabetes Care. 2007;30(3):510–5.
  5. Griffin SJ, Little PS, Hales CN, Kinmonth AL, Wareham NJ. Diabetes risk score: towards earlier detection of type 2 diabetes in general practice. Diabetes Metab Res Rev. 2000;16(3): 164–71.
  6. Glümer C, Carstensen B, Sandbaek A, Lauritzen T, Jørgensen T, Borch-Johnsen K; inter99 study. A Danish diabetes risk score for targeted screening: the Inter99 study. Diabetes Care. 2004;27(3):727–33.
  7. Implementation of Type 2 Diabetes Prevention Plan in Pirkanmaa, South Ostrobothnia, North Ostrobothnia, Northern Savo and Central Finland Hospital districts. Tampere: Finnish Diabetes Association; 2006. 62 p.
  8. Herman WH, Smith PJ, Thompson TJ, Engelgau MM, Aubert RE. A new and simple questionnaire to identify people at increased risk for undiagnosed diabetes. Diabetes Care. 1995;18(3):382–7.
  9. Burnett RW, D'Orazio P, Fogh-Andersen N, Kuwa K, Külpmann WR, Larsson L, Lewnstam A, Maas AH, Mager G, Spichiger-Keller U; Scientific Division, Working Group on Selective Electrodes. IFCC recommendation on reporting results for blood glucose. Clin Chim Acta. 2001;307(1–2):205–9.
  10. World Health Organization. Definition, diagnosis, and classification of Diabetes Mellitus and its complications. Geneva: World Health Organization; 1999/2006.

Copyright (c) 2015 Misnikova I.V., Dreval' A.V., Dzebisashvili T.G.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies